ADRA1B Antikörper (C-Term)
Kurzübersicht für ADRA1B Antikörper (C-Term) (ABIN2196796)
Target
Alle ADRA1B Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 380-409, C-Term
-
Kreuzreaktivität
- Human
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
-
Produktmerkmale
- ADRA1B, CT (ADRA1B, Alpha-1B adrenergic receptor, Alpha-1B adrenoreceptor)
-
Aufreinigung
- Purified by Protein A affinity chromatography.
-
Immunogen
- ADRA1B antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 380-409 amino acids from the C-terminal region of human ADRA1B.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- ADRA1B (Adrenergic, alpha-1B-, Receptor (ADRA1B))
-
Andere Bezeichnung
- ADRA1B
-
NCBI Accession
- NP_000670
-
UniProt
- P35368
-
Pathways
- AMPK Signaling, Carbohydrate Homeostasis, Regulation of Carbohydrate Metabolic Process
Target
-